Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy

信件/通信

開放取用(OA)

同儕審查

Wei-Chun Chen, Ting-Chang Chang 和 Hung-Hsueh Chou

Biomedical Journal, 卷.45(5), 頁碼.849-850

10/2022

PMID: 35065283

摘要

CA-125

HIPEC

Hyperthermic intraperitoneal chemotherapy

Ovarian cancer

Renal failure

Medicine (all)

url

https://doi.org/10.1016/j.bj.2022.01.012檢視

已出版(紀錄版本) 開放

1 檢視次數

題名: Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy
翻譯題名: Reply: Serum CA-125 and renal impairment in patients undergoing hyperthermic intraperitoneal chemotherapy
創作者：: Wei-Chun Chen (作者) - Division of Gynecologic Oncology , Department of Obstetrics and Gynecology , Chang Gung Memorial Hospital at Linkou
Ting-Chang Chang (作者) - Division of Gynecologic Oncology , Department of Obstetrics and Gynecology , Chang Gung Memorial Hospital at Linkou
Hung-Hsueh Chou (作者) - Division of Gynecologic Oncology , Department of Obstetrics and Gynecology , Chang Gung Memorial Hospital at Linkou
學術資源類型: 信件/通信
出版日期: 10/2022
出版資訊: Biomedical Journal, 卷.45(5), 頁碼.849-850
語言: 英語